Krish S. Krishnan, President and CEO, 10% Owner at Krystal Biotech, Inc. (KRYS), sold 25,000 shares at $300.75 ($7.7M) on 2026-06-04, disclosed to the SEC on 2026-06-05.
Scheduled sale ($7.7M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.75 | 320 | $96K | 1.2% |
| 2 | $302.24 | 640 | $193K | 2.5% |
| 3 | $303.17 | 176 | $53K | 0.7% |
| 4 | $304.81 | 544 | $166K | 2.2% |
| 5 | $306.33 | 589 | $180K | 2.3% |
| 6 | $307.68 | 11,461 |
| $3.5M |
| 45.8% |
| 7 | $308.47 | 4,830 | $1.5M | 19.3% |
| 8 | $309.49 | 2,784 | $862K | 11.2% |
| 9 | $310.43 | 2,652 | $823K | 10.7% |
| 10 | $311.36 | 964 | $300K | 3.9% |
| 11 | $312.23 | 40 | $12K | 0.2% |
| Total | $308.12 avg | 25,000 | $7.7M | 100% |
| Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |
| KRYS | SELL | 2025-07-11 | $4.0M | — | Filing → |